glucosylceramide

glucosylceramide

glucosylceramide lipidosis

glucosylceramide lipidosis

glucosylceramide lipidosis

Glucosylceramide synthase inhibitors differentially affect expression of glycosphingolipids

Development of a New Inhibitor of Glucosylceramide Synthase

In vitro characterization of anti-glucosylceramide rabbit antisera

Transfection of glucosylceramide synthase antisense inhibits mouse melanoma formation

Significance of the KlLAC1 gene in glucosylceramide production by Kluyveromyces lactis

Neuronal accumulation of glucosylceramide in a mouse model of neuronopathic Gaucher disease leads to neurodegeneration

Characterization of monoclonal antibody MEST-2 specific to glucosylceramide of fungi and plants

Characterization of glucosylceramides in Pseudallescheria boydii and their involvement in fungal differentiation

Glucosylceramide and Lysophosphatidylcholines as Potential Blood Biomarkers for Drug-Induced Hepatic Phospholipidosis

Amelioration of hepatic fibrosis via beta-glucosylceramide-mediated immune modulation is associated with altered CD8 and NKT lymphocyte distribution

Combined saposin C and D deficiencies in mice lead to a neuronopathic phenotype, glucosylceramide and α-hydroxy ceramide accumulation, and altered prosaposin trafficking

Simultaneous quantification of glucosylceramide and galactosylceramide by normal-phase HPLC using O-phtalaldehyde derivatives prepared with sphingolipid ceramide N-deacylase

RETRACTION of: Amelioration of hepatic fibrosis via beta-glucosylceramide-mediated immune modulation is associated with altered CD8 and NKT lymphocyte distribution

Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits